Advertisement
Research Article| Volume 6, ISSUE 4, P258-260, April 1997

Download started.

Ok

Pathophysiology, monitoring, and treatment of cerebral vasospasm after subarachnoid hemorrhage

  • Marc Mayberg
    Correspondence
    Address reprint requests to Marc Mayberg, MD, Department of Neurological Surgery, Box 356470, University of Washington, Seattle, WA 98195.
    Affiliations
    Department of Neurological Surgery, University of Washington, Seattle, WA., USA
    Search for articles by this author
DOI:https://doi.org/10.1016/S1052-3057(97)80025-0
Pathophysiology, monitoring, and treatment of cerebral vasospasm after subarachnoid hemorrhage
Previous ArticleDecision-making for intracranial aneurysm treatment: When to select surgery, and when to select endovascular therapy
Next ArticleBalloon angioplasty and intra-arterial papaverine for vasospasm
      This paper is only available as a PDF. To read, Please Download here.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Stroke and Cerebrovascular Diseases
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • Mayberg MR
        • Okada T
        • Bark DH
        Morphologic changes in cerebral arteries after subarachnoid hemorrhage.
        Neurosurg Clin North Am. 1990; 1: 417-432
        • Adams Jr, HP
        • Kassell NF
        • Torner JC
        • Haley Jr, EC
        Predicting cerebral ischemia after aneurysmal subarachnoid hemorrhage: Influences of clinical condition, CT results, and antifibrinolytic therapy. A report of the Cooperative Aneurysm Study.
        Neurology. 1987; 37: 1586-1591
        • Shibuya M
        • Suzuki Y
        • Sugita K
        • Saito I
        • et al.
        Effect of AT877 on cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Results of a prospective placebocontrolled double-blind trial.
        J Neurosurg. 1992; 76: 571-577
        • Newell DW
        • Eskridge J
        • Mayberg M
        • Grady MS
        • et al.
        Endovascular treatment of intracranial aneurysms and cerebral vasospasm.
        Clin Neurosurg. 1992; 39: 348-360
        • Le Roux PD
        • Newell DW
        • Eskridge J
        • Mayberg MR
        • et al.
        Severe symptomatic vasospasm: the role of immediate postoperative angioplasty.
        J Neurosurg. 1994; 80: 224-229
        • Harada T
        • Mayberg MR
        Inhibition of delayed arterial narrowing by the iron-chelating agent deferoxamine.
        J Neurosurg. 1992; 77: 763-767
        • Luo Z
        • Harada T
        • London S
        • Gajdusek C
        • Mayberg MR
        Antioxidant and iron-chelating agents in cerebral vasospasm.
        Neurosurgery. 1995; 37: 1154-1158
        • Kassell NF
        • Haley Jr, EC
        • Apperson-Hansen C
        • Alves WM
        Randomized, double-blind, vehicle-controlled trial of tirilizad mesylate in patients with aneurysmal subarachnoid hemorrhage: a cooperative study in Europe, Australia, and New Zealand.
        J Neurosurg. 1995; 82: 221-228
        • Haley Jr, EC
        • Kassell NF
        • Alves WM
        • Weir BK
        • Hansen CA
        Phase II trial of tirilizad in aneurysmal subarachnoid hemorrhage. A report of the Cooperative Aneurysm Study.
        J Neurosurg. 1995; 82: 786-790

      Article info

      Identification

      DOI: https://doi.org/10.1016/S1052-3057(97)80025-0

      Copyright

      © 1997 National Stroke Association. All rights reserved. Published by Elsevier Inc.

      ScienceDirect

      Access this article on ScienceDirect

      The content on this site is intended for healthcare professionals.


      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the Cookie Preference Center for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties.


      RELX